Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Apexbio Technology LLC Moxifloxacin HCl 186826-86-8 50mg
Supplier: Apexbio Technology LLC A532350
Moxifloxacin HCl (186826-86-8) is a small-molecule inhibitor targeting bacterial DNA gyrase (topoisomerase II) and topoisomerase IV It is designed to inhibit these enzymes thereby disrupting essential bacterial DNA replication transcription and repair processes Moxifloxacin HCl exerts its biological activity primarily through inhibition of DNA gyrase and topoisomerase IV It demonstrates antibacterial activity against both Gram-positive and Gram-negative bacteria including ciprofloxacin-resistant strains with MIC90 values for ciprofloxacin-susceptible strains up to 0 6 g/mL Additionally moxifloxacin inhibits human serum paraoxonase-1 (hPON1) with a Ki value of 2 641 0 004 mM Based on these pharmacological properties Moxifloxacin HCl holds research potential in studying antibacterial mechanisms and enzyme-inhibitor interactions
Product Title
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.
Spot an opportunity for improvement?